Komori
Kaken Pharmaceutical (4521) · InitiativeRestated

Faster decision-making and separation of oversight and execution through the executive officer system

First written in FY2017. 4 of 5 entries say "Restated". Latest entry: FY2022.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017 – FY20222017: 120172018: 120182019: 120192020: 020202021: 120212022: 12022
Same theme, other companies
Executive Officer System Separating the Board of Directors from Executive FunctionsA theme 63 companies write about · 0 as a headwind · 63 as a tailwind

22 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 63 companies compared. The sentences above are computed from all 63.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「We have introduced an executive officer system to accelerate decision-making and clarify supervisory and business execution functions.」

    The acceleration of decision-making and clarification of supervisory and execution functions through the executive officer system continues.
  2. FY2021RestatedAnnual report

    「We have introduced an executive officer system to accelerate decision-making and clarify supervisory and business execution functions.」

    The acceleration of decision-making and clarification of supervisory and execution functions through the executive officer system continues.
  3. FY2019RestatedAnnual report

    「We have introduced an executive officer system to accelerate decision-making and clarify supervisory and business execution functions.」

    The structure for accelerating decision-making and clarifying supervisory and execution functions through the executive officer system continues.
  4. FY2018RestatedAnnual report

    「We have introduced an executive officer system to accelerate decision-making and clarify supervisory and business execution functions.」

    The structure for accelerating decision-making and clarifying supervisory and execution functions through the executive officer system continues.
  5. FY2017First statedAnnual report

    「We have introduced an executive officer system to accelerate decision-making and clarify supervisory and business execution functions.」

    An executive officer system is in place to accelerate decision-making and clarify supervisory and business execution functions.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Kaken Pharmaceutical's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.